HOME >> BIOLOGY >> NEWS
Researchers Learn How Nature Produces Cholesterol-Lowering Lovastatin

MADISON, Wis.-- Scientists know that a fuzzy fungus similar to the mold that grows on stale bread and over-ripe fruit produces lovastatin, the natural substance that lowers cholesterol in humans. Now researchers at the University of Wisconsin School of Pharmacy have learned how the fungus makes it.

The UW researchers, who in the past decade have made key discoveries about the way microorganisms produce related substances such as antibiotics and certain cancer-fighting agents, reported their findings in the May 21 Science.

The discovery may prove useful to pharmaceutical companies, which currently manufacture nearly $4 billion of cholesterol-lowering drugs each year, by providing a more efficient, less costly approach. The findings may also be used to genetically alter fungus metabolism to yield more potent drugs. Bacteria and fungi produce hundreds of substances like lovastatin, designed to improve the odds of their own survival. Many of the substances, called polyketides, appear as attractive or repellent aromas, flavors, colors or toxins. Some, like tetracycline and erythromycin, have been found to be medically useful for humans.

Ten years ago UW pharmacy professor C. Richard Hutchinson and scientists in England discovered one process by which microorganisms produce polyketides. The scientists found that six enzymes work together with two or three carbon building blocks to produce a series of biochemical reactions leading ultimately to a complex molecule, a structure that makes a colored pigment. Other scientists at Cambridge University and Abbott Laboratories in Chicago later found a second way microbes make polyketides, utilizing three enzymes and four variations of building blocks. Products of this process are never pigmented, but they can result in erythromycin, which is widely used as an antibacterial drug.

But the UW researchers suspected a third process might exist when they looked closely at one gene associated with lovastatin productio
'"/>

Contact: Dian Land
dj.land@hosp.wisc.edu
608-263-9893
University of Wisconsin-Madison
21-May-1999


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, the leader in ... third highest quality portfolio following Seres Health and Nestle, as published in ... Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and CEO, Dr. Zachary ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... ... configurations on Mac, Windows and mobile, today announces the launch of its North ... sales volume, geographies and vertical markets, enabling them to add FileWave’s industry-leading solutions ...
(Date:3/13/2019)... ... March 13, 2019 , ... Sleep problems constitute a global epidemic that ... the world’s population. One billion people worldwide suffer from sleep apnea - ... than 80 percent of whom go undiagnosed. Today, Beddr , the sleep health ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... ... hospital in Israel and the Middle East region, and Swiss-based CDMO Lonza ... manufacturing platform. The partnership will enable Sheba to vastly streamline its in-house ...
(Date:3/18/2019)... ... ... For more than 15 years, USDM Life Sciences and ... easily comply with FDA 21 CFR Part 11 and EMA EudraLex Volume 4 Annex ... GxP compliance from vendor audit through ongoing validation maintenance, including every new release. ...
(Date:3/14/2019)... ... March 14, 2019 , ... EyeCRO LLC has ... OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma Medical Research Foundation, ... fifth institution in Oklahoma to receive this prestigious endorsement. The award letter ...
(Date:3/14/2019)... ... March 14, 2019 , ... Open registration for the ... Full Spectrum of Case Management,” continues as CMSA makes plans to host the ... only case management industry conference serving the educational and networking needs of case ...
Breaking Biology Technology:
Cached News: